Question:
Under which of the following conditions in-vitro-in-vivo correlation for a drug fails?
Under which of the following conditions in-vitro-in-vivo correlation for a drug fails?
Updated On: Jul 20, 2024
- When the drug’s absorption takes place by a complex
- When the dissolution medium is adequately simulated
- When the drug is highly soluble
- When the drug is highly permeable but poorly soluble
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C): When the drug is highly soluble
Was this answer helpful?
0
0
Top Questions on Bio-availability & Bio-equivalence
- Which type of in-vitro-in-vivo correlation compares % drug released vs % drug absorbed?
- GPAT - 2023
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- Decrease in effective surface area available to the dissolution medium leading to a fall in the dissolution rate, may happen due to which one of the following reasons?
- GPAT - 2022
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- Match List I with List II
List I List II A When two dosage forms have equal t max I When their total body clearance is constant. B AUC values of the two analogs can be compared to measure relative bioavailability II Absorption rate constants are equal C Urinary data is valid to measure bioavailability. III. W III When fraction absorbed and elimination rate is constant. D C max is proportional to the rate of absorption IV Excretion of drug and/or metabolite is related to the bioavailable dose. Choose the correct answer from the options given below:
- GPAT - 2022
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- For solid oral drug products, a change in the concentration of which of the following excipients is more likely to influence the bioavailability of a drug.
- GPAT - 2021
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- For depot injections, in which drug is slowly released over weeks or months, which bioequivalence study design is used?
- GPAT - 2021
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
View More Questions
Questions Asked in GPAT exam
- Core tablet coated with cellulose acetate phthalate has been administered to a patient. Where do you expect the drug to be released:
- GPAT - 2024
- Tablets
- An elixir contains 47 % v/v alcohol, what is the proof spirit according to USP:
- GPAT - 2024
- Liquids(solutions, syrups, elixirs, spirits, aromatic water, liquid for external uses)
- Which of the following is an aryl acetic acid derivative:
- GPAT - 2024
- carbonyl compounds
- Calculate the \( \lambda_{\text{max}} \) of the following molecule:
- GPAT - 2024
- Nucleic acid: replication, transcription, splicing, translation
- The below structure represent the drug:
- GPAT - 2024
- Biogenetic pathways
View More Questions